The pandemic appears to be tempering public disdain toward two of the plaintiffs bar’s most frequent targets: the health care and pharmaceutical industries. Now it’s anyone’s guess whether and how that might impact jury verdicts going forward, but there’s no shortage of theories.

       

Click Here To Read The Full Article